medigraphic.com
ISSN 2007-3194 (Print)
Órgano de difusión oficial del Instituto Materno Infantil del Estado de México

2019, Number 2

<< Back Next >>

Arch Inv Mat Inf 2019; 10 (2)

Epidemiology of developmental hip dysplasia in the State of Mexico

Quiroga-Vilchis LE, González-Gómez M, Vanegas-García DR

Language: Spanish
References: 19
Page: 50-59
PDF size: 148.18 Kb.


ABSTRACT

Introduction: Developmental dysplasia of the hip (DDH) is one of the main diagnosis observed in pediatric orthopedics. National literature reports a prevalence of 2-6 per 100 live births. In the State of Mexico there’s insufficient data respect to the epidemiology for DDH. Objective: Identify the frequency and population distribution of patients with DDH, attending in a public pediatric hospital. Material and methods: Observational, descriptive and transverse study. A systematic review was conducted over the records of patients ranging from 0 to 36 months of age registered with DDH diagnosis. At the Hospital Materno Infantil del Estado de México, within the period of January 2011 to December 2017. Results: 831 patients reviewed for the first time in the pediatrics’ external consultation service with DDH diagnosis and 504 (74%) patients were confirmed with DDH by the Orthopedics’ Service. The incidence measured was 1.5 and the prevalence was 2.4 per 100 consultations. According to the Tonnis grade classification 41% of the cases were type 1, affecting the left side in 47.6 % of the cases and the female gender in 76% of them. The 25% of patients required surgical treatment. The hospital prevalence during the period of 7 years was of 2.7 per 100. The regions of the State of Mexico with more cases registered were: Toluca, Lerma, Ixtapan de la Sal, Atlacomulco and Valle de Bravo. Discussion: It has been documented that CDD is the most frequent musculoskeletal diseases in the orthopedic outpatient clinic. In the pediatric outpatient clinic, CDD was detected in 26% of the cases assessed for the first time from 0 to 6 months of age. In this study, CDD had a prevalence of 24 per thousand patients seen in an outpatient clinic. Conclusions: It’s been documented that DDH has a prevalence of 2.4, affecting the female gender and the left side of the hip, the most frequent age of diagnosis is between 7 and 18 months of age. The regions with the most referred cases could be an epidemiologic risk zone to be targeted in order to develop further research and create a timely prevention.


REFERENCES

  1. Diagnóstico y tratamiento oportuno de la displasia en el desarrollo de la cadera. México: Secretaría de Salud; 2008.

  2. Weinstein SL, Mubarak SJ, Wenger DR. Developmental hip dysplasia and dislocation: Part I, J Bone Joint Surg Am, 2003; 85: 1824-1832.

  3. Guinchard E, Espinosa E, Ruíz R et al. Programa de Actualización Continua en Ortopedia y Traumatología. Displasia del desarrollo de la cadera. Vol. 2. México: Intersistemas; 2000-2001. pp. 71-96.

  4. Kapandji AI. Fisiología articular. Vol. 2. La cadera. 6a ed. Madrid: Editorial Médica Panamericana; 2010. p. 400.

  5. Bautista-Villa A, Mora-Ríos FG, Mejía-Rohenes C, López-Marmolejo A, Escalante-Espinosa HM. Anormalidades y síndromes ortopédicos más comunes en el Hospital Regional General Ignacio Zaragoza, Rev Esp Med Quir, 2015; 20: 3-10.

  6. Weinstein SL, Mubarak SJ, Wenger DR. Developmental hip dysplasia and dislocation: Part II, J Bone Joint Surg Am, 2003; 85: 2024-2035.

  7. Esquivel M. Frecuencia y Asociación con factores de riesgo en niños de 0 a 23 meses de edad con displasia del desarrollo de cadera tratados en el Hospital para el Niño del IMIEM. México: 2016.

  8. Loder R, Skopelja E. The epidemiology and demographics of hip dysplasia, ISRN Orthop, 2011; 2011: 238607. doi: 10.5402/2011/238607.

  9. Woodacre T, Ball T, Cox P. Epidemiology of developmental dysplasia of the hip within the UK: refining the risk factors, J Child Orthop, 2016; 10: 633-642.

  10. Lee CB, Mata-Fink A, Millis M, Kim YJ. Demographic differences in adolescent-diagnosed and adult-diagnosed acetabular dysplasia compared with infantile developmental dysplasia of the hip, J Pediatr Orthop, 2013; 33 (2): 107-111.

  11. Norma Oficial Mexicana-034-SSA2-2013. Para la prevención y control de los defectos al nacimiento. Diario Oficial de la Federación (segunda Sección) 24 de Junio 2014 México.

  12. Tonnis D. Congenital dysplasia and dislocation of the hip in children and adults. Berlin: Springer-Velag; 1987.

  13. Requeiro-Molina J, Machado-Consuegra A, Kautets-Pardiñas-de-León L, Alonso-Leiva L, Morejón-Fernández J, Requeiro-Molina G. Metodología para medir la cadera en etapa cartilaginosa desde el punto de vista radiográfico, Medisur, 2017; 15 (3): 304-309. Disponible en: http://www.medisur.sld.cu/index.php/medisur/article/view/3517

  14. Zhang ZL, Fu Z, Yang JP, Wang K, Xie LW, Deng SZ et al. Intraoperative arthrogram predicts residual dysplasia after successful closed reduction of DDH. Orthop Surg. 2016; 8 (3): 338-344.

  15. Cha SM, Shin HD, Shin BK. Long-term results of closed Reduction for developmental dislocation of the hip in children of walking age under eighteen months old, Int Orthop, 2018; 42 (1): 175-82.

  16. Claro-Hernández JC, Mora-Ríos FG, Mejía-Rohenes C, García-Ramírez VF, Hernández-Laredo O. Epidemiología de la displasia del desarrollo de la cadera, Rev Esp Méd Quir, 2017; 22 (1): 22-27.

  17. Galek-Aldridge MS, De Graeff JJ, Struijs PAA. Closed reduction of congenital dislocation of the hip: Prediction factors and results, J Pediatr Orthop Part B, 2018; 27 (5): 391-393.

  18. Mansour E, Eid R, Romanos E, Ghanem I. The management of residual acetabular dysplasia: updates and controversies, J Pediatr Orthop B, 2017; 26 (4): 344-349.

  19. Cymet-Ramírez J, Álvarez-Martínez MM, García-Pinto G, Frías-Austria R, Meza-Vernis A, Rosales-Muñoz ME et al. El diagnóstico oportuno de la displasia de cadera. Enfermedad discapacitante de por vida. Consenso del Colegio Mexicano de Ortopedia y Traumatología, Act Ortop Mex, 2011; 25 (5): 313-322.




2020     |     www.medigraphic.com